ALKS

Alkermes plc News Headlines

$46.12
*  
0.84
1.86%
Get ALKS Alerts
*Delayed - data as of Oct. 24, 2014 11:17 ET  -  Find a broker to begin trading ALKS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALKS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
ALKS Crosses Above Key Moving Average Level
9/18/2014 12:01:00 PM - BNK Invest


Cramer's Lightning Round - Edwards LifeSciences Is The Hottest Game In Town (9/15/14)
9/16/2014 6:15:00 AM - Seeking Alpha


First Week of October 18th Options Trading For Alkermes (ALKS)
9/8/2014 11:21:59 AM - BNK Invest


Alkermes To Present At Morgan Stanley Conference; Webcast At 11:05 AM ET
9/8/2014 10:00:00 AM - RTT News


Alkermes Completes Enrolment for Phase II ALKS 3831 Study - Analyst Blog
9/4/2014 6:10:00 PM - Zacks.com


Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog
8/26/2014 7:00:00 PM - Zacks.com


Sector Update: Health-Care Shares Flat Pre-Market
8/26/2014 8:48:38 AM - MT Newswires


Sector Update: Health Care
8/26/2014 8:47:46 AM - MT Newswires


ADXS Makes It Big, ALKS Waiting To Face FDA, ITMN Snapped Up, KITE Flies High
8/26/2014 12:52:00 AM - RTT News


Alkermes Submits NDA To FDA For Schizophrenia Treatment Aripiprazole Lauroxil
8/25/2014 7:17:00 AM - RTT News


Thursday's ETF Movers: BBH, GXC
8/14/2014 3:52:33 PM - BNK Invest


Drug Patent Expirations This Week: UCB, Roche's Genentech
8/8/2014 9:17:00 AM - Seeking Alpha


Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
8/4/2014 3:40:00 PM - Zacks.com


Alkermes Reports Q2 Non-GAAP EPS Of $0.11; Updates FY14 Guidance
7/31/2014 7:30:00 AM - RTT News


Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog
7/30/2014 12:04:00 PM - Zacks.com


Alkermes' Pipeline Development Impresses, Key Updates Ahead - Analyst Blog
7/21/2014 4:40:00 PM - Zacks.com


Alkermes plc (ALKS) Jumps: Stock Rises 5.7% - Tale of the Tape
6/23/2014 9:21:00 AM - Zacks.com


Alkermes' Aripiprazole Lauroxil Looks Promising - Analyst Blog
6/19/2014 11:40:00 AM - Zacks.com


Sector Update: Healthcare
6/18/2014 8:55:02 AM - MT Newswires


Sector Update: Healthcare Shares Flat Pre-Market; Pfizer Teams with Cellectis on Immunotherapy
6/18/2014 8:51:02 AM - MT Newswires


Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha


Alkermes Progresses with its Late Stage Candidate - Analyst Blog
6/11/2014 5:00:00 PM - Zacks.com


Alkermes' Pipeline Holds Promise - Analyst Blog
6/6/2014 4:30:00 PM - Zacks.com


Wider-than-expected Loss at Alkermes, Revenues Slip - Analyst Blog
5/1/2014 11:50:01 AM - Zacks.com


Sector Update: Healthcare
4/30/2014 8:54:36 AM - MT Newswires